The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
A | Alimentary tract and metabolism | |
2
|
A10 | Drugs used in diabetes | |
3
|
A10B | Blood glucose lowering drugs, excl. insulins | |
4
|
A10BD | Combinations of oral blood glucose lowering drugs | |
5
|
A10BD08 | Metformin and vildagliptin |
| Active Ingredient |
|---|
|
Combination of two antihyperglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: vildagliptin, a member of the islet enhancer class, and metformin hydrochloride, a member of the biguanide class. |
| Document | Type | Information Source | |
|---|---|---|---|
| EUCREAS Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| GALVUS MET Film-coated tablet | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| JALRAMET Film-coated tablet | MPI, Generic | Health Products Regulatory Authority (ZA) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.